DEFA14A: Masimo Urges Stockholders to Resubmit Votes Following Proxy Statement Revisions Amidst Board Nominee Challenge

Masimo Corporation is urging its stockholders to resubmit their votes for the 2024 Annual Meeting following revisions to its proxy statement, amidst a challenge from Politan Capital Management LP.

Summary

• Masimo Corporation has released additional materials related to its upcoming 2024 Annual Meeting of Stockholders.
• The company is facing a challenge from Politan Capital Management LP, which has nominated director candidates for election at the meeting.
• Masimo filed a revised proxy statement on August 15, 2024, and an amended revised proxy statement on August 22, 2024.
• Stockholders are strongly encouraged to read the amended revised proxy statement and accompanying updated gold proxy card, as they contain important information.
• Any votes submitted prior to the filing of the revised proxy statement will not be counted, and all stockholders need to resubmit their votes.
• The company's directors and executive officers may be deemed participants in the solicitation of proxies.
• The document includes forward-looking statements that are subject to risks and uncertainties.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the CEO expresses confidence in the team and technology, the proxy contest introduces uncertainty and potential disruption.

Positives

• CEO Joe Kiani emphasizes the strength of the Masimo team and its contributions to patient care.
• Masimo's technology has significantly reduced blindness in infants, saving an estimated 350,000 years of eyesight.
• The company is actively communicating with stockholders regarding the upcoming annual meeting and proxy voting process.

Negatives

• The proxy contest initiated by Politan Capital Management LP introduces uncertainty and potential costs.
• The need for stockholders to resubmit votes may cause confusion or disenfranchisement.
• The document highlights potential management distraction due to the proxy contest.

Risks

• Uncertainties regarding future actions by Politan Capital Management LP.
• Potential costs and management distraction related to the proxy contest.
• Risks associated with Masimo's ability to drive long-term value creation.
• The company's forward-looking statements are subject to various risk factors detailed in its SEC filings.

Future Outlook

The document focuses on the upcoming 2024 Annual Meeting and the proxy contest, with forward-looking statements qualified by cautionary language regarding risks and uncertainties.

Management Comments

• Joe Kiani: 'One key takeaway is, we have really built this incredible team. You know, it reminds me of the 1990s Bulls.'
• Joe Kiani: 'This team, theres so much more we have to deliver that will not only help patients, but when we help patients, we help our stockholders.'
• Joe Kiani: 'So, we gotta keep this incredible team together; it will be such a shame if it just disperses.'
• Joe Kiani: 'Two thousand babies in America were going blind every year. And now, this technology has been out in the NICUs for over twenty years; youre talking like three hundred and fifty thousand years of eyesight that weve given.'
• Joe Kiani: 'The babies who needed thick, Coca Cola bottle glasses or needed laser surgeries, virtually eliminated thanks to our accurate pulse oximeters.'

Industry Context

The proxy contest suggests potential disagreements on the company's strategic direction, which is not uncommon in the medical technology industry. Activist investors like Politan often seek to influence company strategy to enhance shareholder value.

Stakeholder Impact

• The outcome of the proxy contest could impact the company's strategic direction and, consequently, shareholder value.
• The potential for management distraction could affect employees and the company's ability to innovate.
• The company's focus on patient care remains a key consideration for all stakeholders.

Next Steps

• Stockholders need to review the amended revised proxy statement and resubmit their votes.
• Masimo will proceed with the 2024 Annual Meeting of Stockholders.

Key Dates

Keywords

proxy statement, Masimo, stockholders, annual meeting, Politan Capital Management, director nominees, votes, Kiani